NCT04145349 2025-12-08CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and CompanyPhase 1/2 Active not recruiting30 enrolled 16 charts
NCT05266196 2023-08-01A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Salarius Pharmaceuticals, LLCPhase 1/2 Unknown10 enrolled